Predicting the Causal Effect Relationship Between COPD and Cardio Vascular Diseases

Debjani Panda, Satya Ranjan Dash, Ratula Ray, Shantipriya Parida

Abstract


Coronary Obstructive Pulmonary Disease (COPD) is one of the critical factors that areaffecting the health of the population worldwide and in most cases affects the patientwith cardiovascular diseases and their mortality. The onset of COPD in a patient in mostof the cases affects him/her with cardio vascular disease and the management of the dis-ease becomes more complex for medical practitioners to handle. The factors affectingCOPD and cardiovascular disease in patients are most of the times, concurrent and areresponsible for their mortality. The list of factors and their underlying causes have beenidentified by experts and are treated with utmost importance before the patient suffersfrom an emergency condition and its management becomes even more difficult.This paper discusses the need to study COPD and the factors affecting it to avoidcardiovascular deaths. The dataset used for the study is a novel one and has beencollected from a Government Medical College, for study and experimentation. Classi-fication methods like Decision Trees, Random Forest (RF), Logistic Regression (LR),SVM (Support Vector Machine), KNN (K-Nearest Neighbours) and Naive Bayes havebeen used and Random Forests have given the best results with 87.5% accuracy. Theimportance of the paper is in the attempt to infer important links between the associ-ated features to predict COPD. To the best of our knowledge, such an attempt to inferthe decision regarding the prediction of COPD using Machine Learning classifiers hasnot been made yet. We have attempted to show an important correlation between theassociated features of COPD and compare different supervised classifiers to check theprediction performance after pre-processing the raw data. Coronary Pulmonate, Age,and Smoking have shown a strong correlation with the presence of COPD and the per-formance analyses of the classifiers have been shown using the ROC (Receiver OperatingCharacteristic) curve.

Full Text:

PDF

References


G. E. Batista, R. C. Prati, and M. C.

Monard. A study of the behavior of several methods for balancing machine learning

training data. ACM SIGKDD explorations

newsletter, 6(1):20–29, 2004.

M. Cazzola, L. Calzetta, B. Rinaldi, C. Page,

G. Rosano, P. Rogliani, and M. G. Matera. Management of chronic obstructive pulmonary disease in patients with cardiovascular diseases. Drugs, 77(7):721–732, 2017.

J. R. Feary, L. C. Rodrigues, C. J. Smith,

R. B. Hubbard, and J. E. Gibson. Prevalence

of major comorbidities in subjects with copd

and incidence of myocardial infarction and

stroke: a comprehensive analysis using data

from primary care. Thorax, 65(11):956–962,

F. M. Franssen and C. L. Rochester. Comorbidities in patients with copd and pulmonary

rehabilitation: do they matter?, 2014.

Y. Fukuchi. The aging lung and chronic obstructive pulmonary disease: similarity and

difference. Proceedings of the American Thoracic Society, 6(7):570–572, 2009.

K. Ghoorah, A. De Soyza, and V. Kunadian.

Increased cardiovascular risk in patients with

chronic obstructive pulmonary disease and

the potential mechanisms linking the two

conditions: a review. Cardiology in review,

(4):196–202, 2013.

K. E. Holm, M. R. Plaufcan, D. W. Ford,

R. A. Sandhaus, M. Strand, C. Strange, and

F. S. Wamboldt. The impact of age on outcomes in chronic obstructive pulmonary dis-

COPD and Cardio Vascular Diseases Informatica 37 page 501–yyy 11

ease differs by relationship status. Journal of

behavioral medicine, 37(4):654–663, 2014.

S. Khan, P. Fell, and P. James. Smokingrelated chronic obstructive pulmonary disease (copd). Diversity and Equality in Health

and Care, 11(3-4):267–271, 2014.

R. Laniado-Labor´ın. Smoking and chronic

obstructive pulmonary disease (copd). parallel epidemics of the 21st century. International journal of environmental research and

public health, 6(1):209–224, 2009.

J. D. Maclay and W. MacNee. Cardiovascular disease in copd: mechanisms. Chest, 143

(3):798–807, 2013.

R. Mitchell, J. Michalski, and T. Carbonell.

An artificial intelligence approach. Springer,

D. Panda and S. R. Dash. Predictive system: Comparison of classification techniques

for effective prediction of heart disease. In

Smart Intelligent Computing and Applications, pages 203–213. Springer, 2020.

A. I. Papaioannou, K. Bartziokas,

S. Loukides, S. Tsikrika, F. Karakontaki, A. Haniotou, S. Papiris, D. Stolz, and

K. Kostikas. Cardiovascular comorbidities in

hospitalised copd patients: a determinant of

future risk? European Respiratory Journal,

(3):846–849, 2015.

B. N. Patel, S. G. Prajapati, and K. I.

Lakhtaria. Efficient classification of data

using decision tree. Bonfring International

Journal of Data Mining, 2(1):06–12, 2012.

J. Quint. The relationship between copd and

cardiovascular disease. Tanaffos, 16(Suppl

:S16, 2017.

K. F. Rabe, J. R. Hurst, and S. Suissa. Cardiovascular disease and copd: dangerous liaisons? European Respiratory Review, 27

(149), 2018.

L. Roever et al. Translational medicine.

A. Shujaat, R. Minkin, and E. Eden. Pulmonary hypertension and chronic cor pulmonale in copd. International journal of

chronic obstructive pulmonary disease, 2(3):

, 2007.

D. D. Sin and S. P. Man. Chronic obstructive

pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proceedings of the American Thoracic Society, 2(1):

–11, 2005.

A. Undas, P. Kaczmarek, K. Sladek,

E. Stepien, W. Skucha, M. Rzeszutko,

I. Gorkiewicz-Kot, and W. Tracz. Fibrin clot properties are altered in patients

with chronic obstructive pulmonary disease.

Thrombosis and haemostasis, 102(12):1176–

, 2009.

Y. Yang, J. Li, and Y. Yang. The research

of the fast svm classifier method. In 2015

th International Computer Conference on

Wavelet Active Media Technology and Information Processing (ICCWAMTIP), pages

–124. IEEE, 2015.




DOI: https://doi.org/10.31449/inf.v44i4.3088

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.